The previous week followed an ambiguous format for global financial markets. Positive moods of investors were supported by unprecedented monetary and fiscal incentives and the information about the successful trial of the American coronavirus vaccine developed by Moderna. At the same time, the US Senate’s agreement of a bill to prohibit stock exchange listings of Chinese companies in the US and a threat of further escalation in the relations between the US and China worsened expectations of investors regarding rapid recovery of markets.   

Financial markets survey 25.05.2020